Aeropharm GmbH
PolandAll drugs from this manufacturer
-
The medicine is used in the treatment of bronchial asthma. It contains substances that dilate the airways and reduce swelling and inflammation in the lungs.
Dosage form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 mcg fluticasone propionate 250 mcg ATC: R03AK06
-
The medicinal product is intended for the treatment of bronchial asthma and chronic obstructive pulmonary disease (COPD). It helps to reduce the number of COPD symptom exacerbations.
Dosage form: powder for inhalation, divided
Active substance Dosage salmeterol xinafoate 50 mcg fluticasone propionate 500 mcg ATC: R03AK06
-
The medicine helps to relieve breathing difficulties caused by bronchial asthma and chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. It is also used to prevent asthma symptoms triggered by physical exertion or allergens (e.g., dust, pollen, pet dander, tobacco smoke).
Dosage form: aerosol, inhalation suspension
Active substance Dosage salbutamol sulfate 0.12 mg ATC: R03AC02